Gries Financial LLC Danaher Corp Transaction History

Gries Financial LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$224.58 - $256.19 $120,599 - $137,574	-537 Reduced 25.92%	1,535 $383,000
Q4 2023 Feb 13, 2024	BUY	$185.1 - $233.13 $14,252 - $17,951	77 Added 3.86%	2,072 $479,000
Q3 2023 Nov 14, 2023	SELL	$233.08 - $265.59 $406,724 - $463,454	-1,745 Reduced 46.66%	1,995 $494,000
Q2 2023 Aug 14, 2023	BUY	$224.99 - $256.14 $4,499 - $5,122	20 Added 0.54%	3,740 $897,000
Q1 2023 Jun 21, 2023	BUY	$239.75 - $277.0 $659,792 - $762,304	2,752 Added 284.3%	3,720 $937,000
Q4 2021 Feb 02, 2022	SELL	$292.08 - $329.01 $863,972 - $973,211	-2,958 Reduced 75.34%	968 $318,000
Q3 2021 Nov 12, 2021	SELL	$272.21 - $332.43 $54,441 - $66,486	-200 Reduced 4.85%	3,926 $1.2 Million
Q1 2021 May 17, 2021	BUY	$212.38 - $245.9 $876,279 - $1.01 Million	4,126 New	4,126 $1.04 Million

2,392

563M

3.94M

4.1M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $197B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Gries Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Gries Financial LLC with notifications on news.